CycloHale

Product Overview

Ciclohale is a corticosteroid-based medication containing the active ingredient Ciclesonide. Designed as an inhalation aerosol, it is prescribed for the long-term management of asthma in patients aged 6 years and above. By targeting airway inflammation, Ciclohale helps maintain open airways, thereby preventing asthma symptoms and reducing the frequency of attacks.

Therapeutic Applications

This medication is primarily indicated for:
– Chronic asthma management
– Symptom control (wheezing, dyspnea, chest tightness)
– Maintenance therapy for persistent asthma
– Off-label use in certain COPD cases (under medical supervision)

Administration Guidelines

For optimal results:
1. Shake inhaler vigorously before each use
2. Exhale completely before administration
3. Form tight seal around mouthpiece
4. Inhale deeply while activating canister
5. Hold breath for 10 seconds post-inhalation
6. Rinse mouth thoroughly after each use to prevent oral candidiasis

Mechanism of Action

Ciclohale exerts its therapeutic effects through:
– Local anti-inflammatory action in bronchial tissues
– Inhibition of inflammatory cytokine production
– Reduction of mucosal edema
– Decreased airway hyperresponsiveness
– Suppression of inflammatory cell migration

Dosing Protocol

Recommended dosage ranges:
– Adults/adolescents (≥12 years): 80-320 mcg BID
– Pediatric (6-11 years): 40-160 mcg BID
Note: Dosage adjustments should be made gradually under physician supervision based on therapeutic response and asthma control.

Therapeutic Advantages

Key benefits include:
– Sustained airway inflammation control
– Reduced reliance on rescue medications
– Improved pulmonary function parameters
– Enhanced quality of life metrics
– Decreased frequency of exacerbations
– Favorable safety profile for long-term use

Adverse Effects

Commonly reported reactions:
– Oropharyngeal: Thrush, dysphonia, pharyngitis
– Respiratory: Cough, nasopharyngitis
– Neurological: Cephalgia
– Systemic effects are rare with proper technique

Precautions

Special considerations:
– Contraindicated in acute asthma attacks
– Caution required in patients with:
– Active/suspected respiratory infections
– Systemic fungal infections
– Hepatic impairment
– Potential drug interactions with:
– Strong CYP3A4 inhibitors
– Other corticosteroids
– Pregnancy/Lactation: Category C – use only if benefit justifies risk

Storage Requirements

Proper handling includes:
– Store at controlled room temperature (15-30°C)
– Protect from moisture and direct sunlight
– Keep away from heat sources/open flames
– Monitor dose counter and replace when empty
– Properly dispose of expired devices

Medical Disclaimer

The information provided is for educational purposes only and does not constitute medical advice. While we strive for accuracy, this content is not exhaustive and may not reflect the most current medical knowledge. Always consult your healthcare provider for:
– Diagnosis and treatment decisions
– Complete safety information
– Potential drug interactions
– Individualized medical advice
This resource is intended to complement, not replace, professional medical judgment.